Extra daily virus protection at the point of entry.
For adults and children over the age of one.
It blocks the entry of viruses into cells, thus protecting against highly infectious viral infections of the upper respiratory tract (influenza and colds, influenza virus and coronavirus, and against COVID-19, caused by the SARS-CoV-2 coronavirus).
It blocks the multiplication of viruses, and thus prevents the appearance of symptoms of the disease.
Protects against the spread of the virus (by limiting transmission from symptomatic or asymptomatic infected people to others).
It protects against dryness and irritation of the nasal mucosa by environmental factors that may facilitate the entry of viruses into cells and multiplication.
It soothes the symptoms of viral infections of the upper respiratory tract, including rhinitis (caused by influenza viruses and coronaviruses, including SARS-CoV-2) and reduces a dry throat.
It shortens the duration of the disease caused by a viral infection of the nasal mucosa.
It reduces the likelihood of bacterial superinfection that often follows viral infection.
1 dose in each nostril at intervals of 4-5 hours between applications.
Possibility of regular use every 4-5 hours, or ad hoc as needed.
Ingredients responsible for the operation of the product: iota-carrageenan, sodium hyaluronate, ectoine.
Excipients: propylene glycol, citric acid, sodium hydrogen phosphate, sodium phosphate, water and a preservative.